These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 29767670)

  • 21. Identification of a Novel CSNK2A1-PDGFRB Fusion Gene in a Patient with Myeloid Neoplasm with Eosinophilia.
    Xu X; Lu Q; Wang Z; Cai P; Zeng Z; Zhang L; Wang M; Ma L; Ruan C; Chen S
    Cancer Res Treat; 2021 Jul; 53(3):889-892. PubMed ID: 33421986
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Myeloid neoplasm with eosinophilia and
    Salehi S; Astle JM; Sadigh S; Lake J; Aikawa V; Tang G; Wang SA; Bagg A
    Leuk Lymphoma; 2019 Sep; 60(9):2299-2303. PubMed ID: 30806106
    [No Abstract]   [Full Text] [Related]  

  • 23. Myeloproliferative neoplasms with t(8;22)(p11.2;q11.2)/BCR-FGFR1: a meta-analysis of 20 cases shows cytogenetic progression with B-lymphoid blast phase.
    Montenegro-Garreaud X; Miranda RN; Reynolds A; Tang G; Wang SA; Yabe M; Wang W; Fang L; Bueso-Ramos CE; Lin P; Medeiros LJ; Lu X
    Hum Pathol; 2017 Jul; 65():147-156. PubMed ID: 28551329
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A novel TRIP11-FLT3 fusion in a patient with a myeloid/lymphoid neoplasm with eosinophilia.
    Chung A; Hou Y; Ohgami RS; Von Gehr A; Fisk DG; Roskin KM; Li X; Gojenola L; Bangs CD; Arber DA; Fire AZ; Cherry AM; Zehnder JL; Gotlib J; Merker JD
    Cancer Genet; 2017 Oct; 216-217():10-15. PubMed ID: 29025582
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diagnostic application of next-generation sequencing in ZMYM2-FGFR1 8p11 myeloproliferative syndrome: A case report.
    Wang Y; Wu X; Deng J; Yu H; Xu R; Zhu Z; Tu S; Hu Y
    Cancer Biol Ther; 2016 Aug; 17(8):785-9. PubMed ID: 27415155
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 8p12 stem cell myeloproliferative disorder: the FOP-fibroblast growth factor receptor 1 fusion protein of the t(6;8) translocation induces cell survival mediated by mitogen-activated protein kinase and phosphatidylinositol 3-kinase/Akt/mTOR pathways.
    Guasch G; Ollendorff V; Borg JP; Birnbaum D; Pébusque MJ
    Mol Cell Biol; 2001 Dec; 21(23):8129-42. PubMed ID: 11689702
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel t(5;11)(q32;q13.4) with NUMA1-PDGFRB fusion in a myeloid neoplasm with eosinophilia with response to imatinib mesylate.
    Zou YS; Hoppman NL; Singh ZN; Sawhney S; Kotiah SD; Baer MR
    Cancer Genet; 2017 Apr; 212-213():38-44. PubMed ID: 28449810
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Activity of fibroblast growth factor receptor inhibitors TKI258, ponatinib and AZD4547 against TPR‑FGFR1 fusion.
    Qiu XH; Li F; Cao HQ; Shao JJ; Mei JG; Li HQ; Zhai YP
    Mol Med Rep; 2017 Mar; 15(3):1024-1030. PubMed ID: 28138694
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Activity of TKI258 against primary cells and cell lines with FGFR1 fusion genes associated with the 8p11 myeloproliferative syndrome.
    Chase A; Grand FH; Cross NC
    Blood; 2007 Nov; 110(10):3729-34. PubMed ID: 17698633
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Screening of drugs to treat 8p11 myeloproliferative syndrome using patient-derived induced pluripotent stem cells with fusion gene CEP110-FGFR1.
    Yamamoto S; Otsu M; Matsuzaka E; Konishi C; Takagi H; Hanada S; Mochizuki S; Nakauchi H; Imai K; Tsuji K; Ebihara Y
    PLoS One; 2015; 10(3):e0120841. PubMed ID: 25803811
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Myeloid and lymphoid neoplasm with abnormalities of FGFR1 presenting with trilineage blasts and RUNX1 rearrangement: a case report and review of literature.
    Kumar KR; Chen W; Koduru PR; Luu HS
    Am J Clin Pathol; 2015 May; 143(5):738-48. PubMed ID: 25873510
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Concomitant myeloproliferative neoplasm with eosinophilia, B and T cell lymphoblastic lymphoma/leukemia and mast cell proliferation driven by ZMYM2::FGFR1 rearrangement.
    Loscocco GG; Ascani S; Mannelli F; Zanelli M; Rotunno G; Santi R; Vannucchi AM
    Am J Hematol; 2023 Dec; 98(12):1959-1962. PubMed ID: 37435901
    [No Abstract]   [Full Text] [Related]  

  • 33. Myeloid/lymphoid neoplasm with FGFR1 rearrangement.
    Germans SK; Chen M
    Blood; 2021 Sep; 138(10):912. PubMed ID: 34499152
    [No Abstract]   [Full Text] [Related]  

  • 34. The 8p11 myeloproliferative syndrome owing to rare FGFR1OP2-FGFR1 fusion.
    Onozawa M; Ohmura K; Ibata M; Iwasaki J; Okada K; Kasahara I; Yamaguchi K; Kubota K; Fujisawa S; Shigematsu A; Endo T; Kondo T; Hashino S; Tanaka J; Matsuno Y; Asaka M; Imamura M
    Eur J Haematol; 2011 Apr; 86(4):347-9. PubMed ID: 21198859
    [No Abstract]   [Full Text] [Related]  

  • 35. t(8;22)/BCR-FGFR1 myeloproliferative disorder presenting as B-acute lymphoblastic leukemia: report of a case treated with sorafenib and review of the literature.
    Wakim JJ; Tirado CA; Chen W; Collins R
    Leuk Res; 2011 Sep; 35(9):e151-3. PubMed ID: 21628071
    [No Abstract]   [Full Text] [Related]  

  • 36. Unusual infant eosinophilia: myeloid neoplasm with FGFR1 abnormality.
    Li W; Cooley LD
    Blood; 2016 Sep; 128(10):1440. PubMed ID: 27769039
    [No Abstract]   [Full Text] [Related]  

  • 37. Myeloproliferative disorder with eosinophilia and ETV6-ABL gene rearrangement: efficacy of second-generation tyrosine kinase inhibitors.
    Nand R; Bryke C; Kroft SH; Divgi A; Bredeson C; Atallah E
    Leuk Res; 2009 Aug; 33(8):1144-6. PubMed ID: 19394693
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Myeloid/lymphoid neoplasms with FGFR1 rearrangement.
    Strati P; Tang G; Duose DY; Mallampati S; Luthra R; Patel KP; Hussaini M; Mirza AS; Komrokji RS; Oh S; Mascarenhas J; Najfeld V; Subbiah V; Kantarjian H; Garcia-Manero G; Verstovsek S; Daver N
    Leuk Lymphoma; 2018 Jul; 59(7):1672-1676. PubMed ID: 29119847
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Next generation sequencing of myeloid neoplasms with eosinophilia harboring the FIP1L1-PDGFRA mutation.
    Pardanani A; Lasho T; Barraco D; Patnaik M; Elala Y; Tefferi A
    Am J Hematol; 2016 Mar; 91(3):E10-1. PubMed ID: 26663400
    [No Abstract]   [Full Text] [Related]  

  • 40. A case of 8p11 myeloproliferative syndrome with BCR-FGFR1 gene fusion presenting with trilineage acute leukemia/lymphoma, successfully treated by cord blood transplantation.
    Morishige S; Oku E; Takata Y; Kimura Y; Arakawa F; Seki R; Imamura R; Osaki K; Hashiguchi M; Yakushiji K; Mizuno S; Yoshimoto K; Nagafuji K; Ohshima K; Okamura T
    Acta Haematol; 2013; 129(2):83-9. PubMed ID: 23171834
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.